Perioperative Medication Management

  • Sabeena SetiaEmail author


The management of a patient’s home medication regimen around a surgical procedure is an essential component of perioperative medicine. Clinicians must consider which routine medications might cause harm versus which are essential to controlling the underlying medical condition(s) during the perioperative period. This chapter provides guidance for clinicians in this risk–benefit assessment while acknowledging that there is a general lack of outcome data about routine medication management in the perioperative setting.


Perioperative Medication management Preoperative 


  1. 1.
    Hollmann C, Fernandes NL, Biccard BM. A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery. Anesth Analg. 2018;127:678.CrossRefGoogle Scholar
  2. 2.
    Devereaux PJ, Mrkobrada M, Sessler D. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014;370:1494–150.CrossRefGoogle Scholar
  3. 3.
    Gerstein NS, Schulman PM, Gerstein WH, et al. Should more patients continue aspirin therapy perioperatively? Clinical impact of aspirin withdrawal syndrome. Ann Surg. 2012;255(5):811–9.CrossRefGoogle Scholar
  4. 4.
    Khan NA, Campbell NR, Frost SD, et al. Risk of intraoperative hypotension with loop diuretics: a randomized controlled trial. Am J Med. 2010;123:1059e1–8.CrossRefGoogle Scholar
  5. 5.
    Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39:967–76.CrossRefGoogle Scholar
  6. 6.
    Schouten O, Boersma E, Hoeks SE, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361:980–9.CrossRefGoogle Scholar
  7. 7.
    Chopra V, Wesorick DH, Sussman JB, et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay. Arch Surg. 2012;147(2):181–9.CrossRefGoogle Scholar
  8. 8.
    Hussain T, Kneeshaw PJ. Stopping tamoxifen peri-operatively for VTE risk reduction: a proposed management algorithm. Int J Surg. 2012;10(6):313–6.CrossRefGoogle Scholar
  9. 9.
    Ellis AJ, Hendrick VM, Williams R, Komm BS. Selective estrogen receptor modulators in clinical practice: a safety overview. Expert Opin Drug Saf. 2015;14(6):921–34.CrossRefGoogle Scholar
  10. 10.
    Andreasen JJ, Riis A, Hjortdal VE, et al. Effect of selective serotonin reuptake inhibitors on requirement for allogeneic red blood cell transfusion following coronary artery bypass surgery. Am J Cardiovasc Drugs. 2006;6:243–50.CrossRefGoogle Scholar
  11. 11.
    Xiong GL, Jiang W, Clare RM, et al. Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting. Clin Cardiol. 2010;33(6):E94–8.CrossRefGoogle Scholar
  12. 12.
    Auerbach AD, Vittinghoff E, Maselli J, et al. Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery. JAMA Intern Med. 2013;173(12):10751081.CrossRefGoogle Scholar
  13. 13.
    Mahdanian AA, Rej S, Bacon SL, Ozdin D, Lavoie KL, Looper K. Serotonergic antidepressants and perioperative bleeding risk: a systematic review. Expert Opin Drug Saf. 2014;13(6):695–704.PubMedGoogle Scholar
  14. 14.
    Hakkarainen TW, Steele SR, Bastaworous A, et al. Nonsteroidal anti-inflammatory drugs and the risk for anastomotic failure, a report from Washington State’s Surgical Care and Outcomes Assessment Program (SCOAP). JAMA Surg. 2015;150(3):223–8.CrossRefGoogle Scholar
  15. 15.
    Haddad NN, et al. Perioperative use of nonsteroidal anti-inflammatory drugs and the risk of anastomotic failure in emergency general surgery. J Trauma Acute Care Surg. 2017;83(4):657–61.CrossRefGoogle Scholar
  16. 16.
    Zywel MG, Stroh A, Lee SY, Bonutti PM, Mont MA. Chronic opioid use prior to total knee arthoplasty. J Bone Joint Surg Am. 2011;93:1988–93.CrossRefGoogle Scholar
  17. 17.
    Goodman SM, Spring B, Guyatt G. American College of Rheumatology/American Association of hip and knee surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Care Res. 2017;69:1111–24.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Medicine, Division of General Internal MedicineUniversity of WashingtonSeattleUSA

Personalised recommendations